Glycomics/Glycobiology Market: Trends, Opportunities and Competitive Analysis [2023-2028]
2 – 3 business days by ordering today
Glycomics/Glycobiology Market Trends and Forecast
The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.8% from 2023 to 2028. The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Glycomics/Glycobiology Market by Segment
The study includes trends and forecast for the global glycomics/glycobiology market by product, application, end use industry, and region, as follows:
Glycomics/Glycobiology Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Glycosyltransferases & Sialyltransferases
Others
Chromatography Instruments
Arrays
Others
Monosaccharides
Others
Others
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, glycomics/glycobiology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glycomics/glycobiology companies profiled in this report include-
Q1. What is the glycomics/glycobiology market size?
Answer: The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028.
Q2. What is the growth forecast for glycomics/glycobiology market?
Answer: The global glycomics/glycobiology market is expected to grow with a CAGR of 14.8% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the glycomics/glycobiology market?
Answer: The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
Q4. What are the major segments for glycomics/glycobiology market?
Answer: The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics.
Q5. Who are the key glycomics/glycobiology companies?
Answer: Some of the key glycomics/glycobiology companies are as follows:
Answer:Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.
Q7. In glycomics/glycobiology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the glycomics/glycobiology market by product (enzymes, instruments, carbohydrates, and reagents & chemicals), application (drug discovery & development, disease diagnostics, and others), end use industry (academic and research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to glycomics/glycobiology market or related to glycomics/glycobiology companies, glycomics/glycobiology market size, glycomics/glycobiology market share, glycomics/glycobiology analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Glycomics/Glycobiology Market Trends and Forecast
The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.8% from 2023 to 2028. The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Glycomics/Glycobiology Market by Segment
The study includes trends and forecast for the global glycomics/glycobiology market by product, application, end use industry, and region, as follows:
Glycomics/Glycobiology Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Enzymes
Glycosyltransferases & Sialyltransferases
Others
- Instruments
Chromatography Instruments
Arrays
Others
- Carbohydrates
Monosaccharides
Others
- Reagents & Chemicals
- Drug Discovery & Development
- Disease Diagnostics
Others
- Others
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, glycomics/glycobiology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glycomics/glycobiology companies profiled in this report include-
- Merck
- Agilent
- Thermo Fisher Scientific
- New England Biolabs
- Shimadzu
- Takara Bio
- S-BIO
- Waters
- Asparia Glycomics
- Bio-Techne
- Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.
- Academic and research institutes are expected to remain the largest segment due to the increasing investment in research and development activities and growing adoption of glycan structure data analysis by research centers.
- North America will remain the largest region due to an increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
- Market Size Estimates:Glycomics/glycobiology market size estimation in terms of value ($B)
- Trend And Forecast Analysis:Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis:Glycomics/glycobiology market size by various segments, such as product, application, end use industry, and region
- Regional Analysis:Glycomics/glycobiology market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities:Analysis on growth opportunities in different products, applications, end use industries, and regions for the glycomics/glycobiology market.
- Strategic Analysis:This includes M&A, new product development, and competitive landscape for the glycomics/glycobiology market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the glycomics/glycobiology market size?
Answer: The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028.
Q2. What is the growth forecast for glycomics/glycobiology market?
Answer: The global glycomics/glycobiology market is expected to grow with a CAGR of 14.8% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the glycomics/glycobiology market?
Answer: The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
Q4. What are the major segments for glycomics/glycobiology market?
Answer: The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics.
Q5. Who are the key glycomics/glycobiology companies?
Answer: Some of the key glycomics/glycobiology companies are as follows:
- Merck
- Agilent
- Thermo Fisher Scientific
- New England Biolabs
- Shimadzu
- Takara Bio
- S-BIO
- Waters
- Asparia Glycomics
- Bio-Techne
Answer:Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.
Q7. In glycomics/glycobiology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the glycomics/glycobiology market by product (enzymes, instruments, carbohydrates, and reagents & chemicals), application (drug discovery & development, disease diagnostics, and others), end use industry (academic and research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to glycomics/glycobiology market or related to glycomics/glycobiology companies, glycomics/glycobiology market size, glycomics/glycobiology market share, glycomics/glycobiology analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Glycomics/Glycobiology Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Glycomics/ Glycobiology Market by Product
3.3.1: Enzymes
3.3.1.1: Glycosidases & Neuramidases
3.3.1.2: Glycosyltransferases & Sialyltransferases
3.3.1.3: Others
3.3.2: Instruments
3.3.2.1: Mass Spectrometry Instruments
3.3.2.2: Chromatography Instruments
3.3.2.3: Arrays
3.3.2.4: Others
3.3.3: Carbohydrates
3.3.3.1: Oligosaccharides
3.3.3.2: Monosaccharides
3.3.3.3: Others
3.3.4: Reagents & Chemicals
3.4: Global Glycomics/ Glycobiology Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Disease Diagnostics
3.4.2.1: Cancer Diagnostics
3.4.2.2: Other Disease Diagnostics
3.4.3: Other Applications
3.5: Global Glycomics/ Glycobiology Market by End Use Industry
3.5.1: Academic and Research Institutes
3.5.2: Pharmaceutical and Biotechnology Companies
3.5.3: Clinical Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Glycomics/Glycobiology Market by Region
4.2: North American Glycomics/Glycobiology Market
4.2.1: North American Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.2.2: North American Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.3: European Glycomics/ Glycobiology Market
4.3.1: European Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.3.2: European Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.4: APAC Glycomics/ Glycobiology Market
4.4.1: APAC Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.4.2: APAC Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.5: ROW Glycomics/ Glycobiology Market
4.5.1: ROW Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.5.2: ROW Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Product
6.1.2: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Application
6.1.3: Growth Opportunities for the Global Glycomics/ Glycobiology Market by End Use Industry
6.1.4: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Region
6.2: Emerging Trends in the Global Glycomics/Glycobiology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Glycomics/Glycobiology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics/Glycobiology Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Merck
7.2: Agilent
7.3: Thermo Fisher Scientific
7.4: New England Biolabs
7.5: Shimadzu
7.6: Takara Bio
7.7: S-BIO
7.8: Waters
7.9: Asparia Glycomics
7.10: Bio-Techne
2. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Glycomics/Glycobiology Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Glycomics/ Glycobiology Market by Product
3.3.1: Enzymes
3.3.1.1: Glycosidases & Neuramidases
3.3.1.2: Glycosyltransferases & Sialyltransferases
3.3.1.3: Others
3.3.2: Instruments
3.3.2.1: Mass Spectrometry Instruments
3.3.2.2: Chromatography Instruments
3.3.2.3: Arrays
3.3.2.4: Others
3.3.3: Carbohydrates
3.3.3.1: Oligosaccharides
3.3.3.2: Monosaccharides
3.3.3.3: Others
3.3.4: Reagents & Chemicals
3.4: Global Glycomics/ Glycobiology Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Disease Diagnostics
3.4.2.1: Cancer Diagnostics
3.4.2.2: Other Disease Diagnostics
3.4.3: Other Applications
3.5: Global Glycomics/ Glycobiology Market by End Use Industry
3.5.1: Academic and Research Institutes
3.5.2: Pharmaceutical and Biotechnology Companies
3.5.3: Clinical Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Glycomics/Glycobiology Market by Region
4.2: North American Glycomics/Glycobiology Market
4.2.1: North American Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.2.2: North American Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.3: European Glycomics/ Glycobiology Market
4.3.1: European Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.3.2: European Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.4: APAC Glycomics/ Glycobiology Market
4.4.1: APAC Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.4.2: APAC Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.5: ROW Glycomics/ Glycobiology Market
4.5.1: ROW Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
4.5.2: ROW Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Product
6.1.2: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Application
6.1.3: Growth Opportunities for the Global Glycomics/ Glycobiology Market by End Use Industry
6.1.4: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Region
6.2: Emerging Trends in the Global Glycomics/Glycobiology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Glycomics/Glycobiology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics/Glycobiology Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Merck
7.2: Agilent
7.3: Thermo Fisher Scientific
7.4: New England Biolabs
7.5: Shimadzu
7.6: Takara Bio
7.7: S-BIO
7.8: Waters
7.9: Asparia Glycomics
7.10: Bio-Techne
